Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Core Points - Lifecore Biomedical, Inc. has granted a restricted stock unit (RSU) award for 15,000 shares and stock options for 30,000 shares to a newly hired employee as part of its Equity Inducement Plan [1][2] - The RSUs will vest on the third anniversary of the grant date, while the stock options will vest one-third on the first anniversary and the remaining shares monthly thereafter, subject to continued employment [3] Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [4] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and partners with global and emerging biopharmaceutical and biotechnology companies [4]